AOD-9604 was investigated as an obesity treatment and did not achieve approval
Therefore, researchers developed SLU-PP-915 partly to address this limitation
Without writing a book and explaining every single trial in detail, Ill share the key takeaway points: Trials #1-4 demonstrated an excellent safety profile in which AOD-9604 was well-tolerated and safe, with next to no difference compared to a placebo Trial #5 saw patients taking the AOD-9604 peptide lose 2.8 kg on a dose of 1 mg, compared to the placebo group losing 0.8 kg over the same time period
Negative side effects may include a paradoxical decrease in energy levels (most likely due to detoxification from methylation) or slight pain at the injection site which diminishes over 5-10 days
Trusted by healthcare providers across USA, this bacteriostatic water offers reliability and safety for inj therapies
Louis, MO), giving maximal oxidation of the biosensor, and 20 mM dithiothreitol (Sigma-Aldrich, St